3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
17
Carcinoma, Hepatocellular
5
Recurrence
4
Neoplasms, Plasma Cell
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Liver Neoplasms
3
Sarcoma
2
NSCLC
2
Lymphoma, Large B-Cell, Diffuse
2
Esophageal Neoplasms
2
Waldenstrom Macroglobulinemia
1
Stomach Neoplasms
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms
1
Melanoma
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Large Granular Lymphocytic
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Immunoglobulin Light-chain Amyloidosis
1
Immunoblastic Lymphadenopathy
1
Glioblastoma
1
Extrapancreatic Neuroendocrine Tumor
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Fluorouracil
34
Leucovorin
31
Oxaliplatin
25
Irinotecan
19
Capecitabine
13
Folfox protocol
12
Cetuximab
12
Chemotherapy, Adjuvant
11
Bevacizumab
9
Neoadjuvant Therapy
8
Drug Therapy
8
XELOX
7
Laparoscopy
7
Endoscopic Mucosal Resection
5
Colonoscopy
5
Surgical Procedures, Operative
4
Gemcitabine
4
Tegafur
3
Radiotherapy
3
Propofol
3
Preoperative Exercise
3
Panitumumab
3
Fentanyl
3
Curcumin
3
Colectomy
3
Aspirin
3
raltitrexed
2
Surveys and Questionnaires
2
Sodium Chloride
2
Simvastatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Colonic Neoplasms
×
Thalidomide
×
Clear all
NCT00890188
2009-05-07
UFUR
National Cheng-Kung University Hospital
Phase 2
Unknown
34 enrolled